Wang, Tao
Bristol-Myers Squibb (United States)
2 papers on CoChatORCID 0000-0002-5866-8148
Most cited papers
- Verified
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA 1 ) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases
Cheng, P. T. W., Kaltenbach, R. F., Zhang, H., Shi, J., Tao, S., Li, J., Kennedy, L. J., Walker, S. J., Shi, Y., Wang, Y., et al. (2021) · Journal of Medicinal Chemistry
Sphingolipid Metabolism and SignalingInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Cited by 61
- Verified
Simvastatin therapy in adolescent mice attenuates HFD-induced depression-like behavior by reducing hippocampal neuroinflammation
Wu, H., Lv, W., Pan, Q., Kalavagunta, P. K., Liu, Q., Qin, G., Cai, M., Zhou, L., Wang, T., Xia, Z., et al. (2019) · Journal of Affective Disorders
Tryptophan and brain disordersTreatment of Major Depression
Cited by 54
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free